MAIA Biotechnology, Inc.
MAIA · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $55 | $42 | $52 |
| - Cash | $11 | $10 | $11 | $10 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $44 | $32 | $42 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$5 | -$5 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$9 | -$5 | -$5 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.27 | -0.18 | -0.16 | -0.14 |
| % Growth | -50% | -12.5% | -14.3% | – |
| Operating Cash Flow | -$3 | -$4 | -$4 | -$4 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3 | -$4 | -$4 | -$4 |